» Articles » PMID: 17669215

Depo-Provera Abrogates Attenuated Lentivirus-induced Protection in Male Rhesus Macaques Challenged Intravenously with Pathogenic SIVmac239

Overview
Journal J Med Primatol
Publisher Wiley
Date 2007 Aug 3
PMID 17669215
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Progesterone administration prior to intravaginal challenge with pathogenic SIVmac239 decreases the protective efficacy of live attenuated vaccines in rhesus macaques.

Methods: To determine if progesterone alters the efficacy of live attenuated vaccines through local or systemic effects, seven male rhesus macaques were immunized with SHIV89.6 and then challenged intravenously with SIVmac239. Three of these animals were treated with Depo-Provera 30 days prior to the SIV challenge.

Results: The SHIV animals had significantly lower plasma viral RNA levels than the unimmunized control monkeys, but the Depo-Provera treated, SHIV-immunized animals did not. Despite the lack of protection, the Depo-Provera SHIV animals had strong SIV specific T-cell responses. However, altered patterns of NK frequency and CD38 T-cell expression prior to SIV challenge were observed in Depo-Provera SHIV animals.

Conclusions: Depo-Provera eliminates live-attenuated lentivirus vaccine efficacy in male rhesus monkeys through systemic effects on antiviral immunity and/or viral replication.

Citing Articles

High-Resolution Quantitative Mapping of Macaque Cervicovaginal Epithelial Thickness: Implications for Mucosal Vaccine Delivery.

Vincent K, Frost P, Motamedi M, Dick Jr E, Wei J, Yang J Front Immunol. 2021; 12:660524.

PMID: 34262561 PMC: 8273733. DOI: 10.3389/fimmu.2021.660524.


Depot medroxyprogesterone acetate (DMPA) enhances susceptibility and increases the window of vulnerability to HIV-1 in humanized mice.

Wessels J, Nguyen P, Vitali D, Mueller K, Vahedi F, Felker A Sci Rep. 2021; 11(1):3894.

PMID: 33594113 PMC: 7887257. DOI: 10.1038/s41598-021-83242-9.


Hormonal Contraception and HIV-1 Acquisition: Biological Mechanisms.

Hapgood J, Kaushic C, Hel Z Endocr Rev. 2018; 39(1):36-78.

PMID: 29309550 PMC: 5807094. DOI: 10.1210/er.2017-00103.


Lower concentrations of chemotactic cytokines and soluble innate factors in the lower female genital tract associated with the use of injectable hormonal contraceptive.

Ngcapu S, Masson L, Sibeko S, Werner L, McKinnon L, Mlisana K J Reprod Immunol. 2015; 110():14-21.

PMID: 25956139 PMC: 4779161. DOI: 10.1016/j.jri.2015.03.007.


Effect of progestins on immunity: medroxyprogesterone but not norethisterone or levonorgestrel suppresses the function of T cells and pDCs.

Huijbregts R, Michel K, Hel Z Contraception. 2014; 90(2):123-9.

PMID: 24674041 PMC: 4874781. DOI: 10.1016/j.contraception.2014.02.006.


References
1.
Mauck C, Callahan M, Baker J, Arbogast K, Veazey R, Stock R . The effect of one injection of Depo-Provera on the human vaginal epithelium and cervical ectopy. Contraception. 1999; 60(1):15-24. DOI: 10.1016/s0010-7824(99)00058-x. View

2.
Petrovas C, Mueller Y, Dimitriou I, Altork S, Banerjee A, Sklar P . Increased mitochondrial mass characterizes the survival defect of HIV-specific CD8(+) T cells. Blood. 2006; 109(6):2505-13. PMC: 1852206. DOI: 10.1182/blood-2006-05-021626. View

3.
Combadere B, Blanc C, Li T, Carcelain G, Delaugerre C, Calvez V . CD4+Ki67+ lymphocytes in HIV-infected patients are effector T cells accumulated in the G1 phase of the cell cycle. Eur J Immunol. 2001; 30(12):3598-603. DOI: 10.1002/1521-4141(200012)30:12<3598::AID-IMMU3598>3.0.CO;2-E. View

4.
Lu F, Abel K, Ma Z, Rourke T, Lu D, Torten J . The strength of B cell immunity in female rhesus macaques is controlled by CD8+ T cells under the influence of ovarian steroid hormones. Clin Exp Immunol. 2002; 128(1):10-20. PMC: 1906365. DOI: 10.1046/j.1365-2249.2002.01780.x. View

5.
Napravnik S, Poole C, Thomas J, Eron Jr J . Gender difference in HIV RNA levels: a meta-analysis of published studies. J Acquir Immune Defic Syndr. 2002; 31(1):11-9. DOI: 10.1097/00126334-200209010-00002. View